We performed the angle dependent magnetoresistance (MR), Hall effect measurements, the temperature dependent magneto-thermoelectric power (TEP) S(T) measurements, and the first-principles calculations to study the electronic properties of orthorhombic phase MoTe2 (Td-MoTe2), which was proposed to be electronically two-dimensional (2D). There are some interesting findings about Td-MoTe2: (1) A scaling approach εθ=(sin 2 θ+γ -2 cos 2 θ) 1/2 is applied, where θ is the magnetic field angle with respect to the c axis of the crystal and γ is the mass anisotropy. Unexpectedly, the electronically 3D character with γ as low as 1.9 is observed in Td-MoTe2; (2) The possible Lifshitz transition and the following electronic structure change can be verified around T~150 K and T~60 K, which is supported by the evidence of the slop changing of the temperature dependence of TEP, the carrier density extracted from Hall resistivity and the onset temperature of γ obtained from the MR measurements. The extremely large MR effect in Td-MoTe2 could originate from the combination of the electron-hole compensation and a particular orbital texture on the electron pocket, which is supported by the calculations of electronic structure. Our results may provide a general scaling relation for the anisotropic MR and help to recognize the origins of the MR effect in other systems, such as the Weyl semimetals and the Dirac ones.
This review highlights advances in material sourcing, molecular mechanisms, clinical progress and new drug design strategies for triptolide from a Chinese medicinal herb, along with some prospects for the future course of development of triptolide.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.